SEC Form 4 · accession 0001127602-16-044810
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathan Folkert
Officer — VP GM Orthopedics
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rsus (restricted Stock Units)F1 | $0.00 | Mar 1, 2016 | A | 2,000 | A | — | Mar 1, 2026 | Common Stock | 2,000 | 2,000 | D |
| Options To Purchase Common StockF2 | $39.87 | Mar 1, 2016 | A | 38,000 | A | — | Mar 1, 2026 | Common Stock | 38,000 | 38,000 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
- F2The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period